Reaction
Renal Vein Thrombosis reporting signals
As of the last recalculation, Renal Vein Thrombosis appears in 656 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 67.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 24 | 67.2 | 67.3 |
| Heparin Sodium | 19 | 45.1 | 45.2 |
| Dexamethasone Sodium Phosphate | 14 | 44.7 | 44.7 |
| Valganciclovir Hydrochloride Powder, | 13 | 34.5 | 34.5 |
| Fondaparinux Sodium | 7 | 27.7 | 27.8 |
| Drospirenone And Ethinyl Estradiol | 33 | 24.9 | 24.9 |
| Cefazolin | 7 | 24.6 | 24.6 |
| Tacrolimus Ointment 0.1% | 78 | 22.4 | 22.4 |
| Tacrolimus Extended-Release Capsules | 78 | 22.4 | 22.4 |
| Valganciclovir | 13 | 22.3 | 22.3 |
| Valganciclovir Hydrochloride | 13 | 22.3 | 22.3 |
| Romiplostim | 10 | 21.4 | 21.4 |
| Everolimus Tablets | 10 | 19.2 | 19.2 |
| Etonogestrel And Ethinyl Estradiol | 11 | 16.0 | 16.0 |
| Alteplase | 6 | 12.8 | 12.8 |
| Eltrombopag Olamine | 8 | 11.1 | 11.1 |
| Rucaparib | 3 | 10.8 | 10.8 |